Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Vincent Colicchio has maintained an Outperform rating on Concentrix (NASDAQ:CNXC) but lowered the price target from $165 to $98.
June 29, 2023 | 4:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Concentrix's price target has been lowered from $165 to $98 by Barrington Research, although the Outperform rating is maintained.
The lowering of the price target by Barrington Research indicates a potential decrease in the stock's value in the short term. However, the maintenance of the Outperform rating suggests that the company is still expected to perform well relative to its peers.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100